Mealey's (October 15, 2018, 1:59 PM EDT) -- WASHINGTON, D.C. — A panel of the Federal Circuit U.S. Court of Appeals on Oct. 12 upheld findings by U.S. Judge Gregory M. Sleet of the District of Delaware that four patents covering thrice-weekly injections of 40mg glatiramer acetate (GA) do not pass muster under Section 103 of The Patent Act, 35 U.S.C. § 103 (Teva Pharmaceuticals USA Inc., et al. v. Sandoz Inc., et al., No. 17-1575, Fed. Cir., 2018 U.S. App. LEXIS 28751)....